GOFEN & GLOSSBERG LLC /IL/ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOFEN & GLOSSBERG LLC /IL/ ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2022$20,644
-99.9%
227,555
-1.9%
0.53%
+6.6%
Q3 2022$17,634,000
-11.0%
231,989
-1.0%
0.50%
-5.3%
Q2 2022$19,818,000
-8.9%
234,446
-5.4%
0.53%
+6.0%
Q1 2022$21,746,000
-6.0%
247,819
-6.3%
0.50%
-0.6%
Q4 2021$23,126,000
+6.7%
264,388
-0.2%
0.50%
-1.8%
Q3 2021$21,675,000
-11.1%
265,041
-0.8%
0.51%
-12.3%
Q2 2021$24,374,000
+6.7%
267,141
-0.1%
0.58%
-1.2%
Q1 2021$22,854,000
-7.3%
267,363
+2.4%
0.59%
-13.3%
Q4 2020$24,666,000
+8.8%
261,206
+0.2%
0.68%
-3.0%
Q3 2020$22,666,000
+1.9%
260,648
+2.3%
0.70%
-6.6%
Q2 2020$22,247,000
+5.9%
254,7190.0%0.75%
-9.2%
Q1 2020$21,002,000
-11.5%
254,719
+1.7%
0.82%
+9.0%
Q4 2019$23,719,000
+9.7%
250,493
+0.7%
0.75%
+3.4%
Q3 2019$21,622,000
-5.1%
248,810
-0.3%
0.73%
-6.5%
Q2 2019$22,786,000
-5.2%
249,550
-0.2%
0.78%
-8.5%
Q1 2019$24,034,000
+12.4%
249,987
+0.3%
0.85%
+0.8%
Q4 2018$21,377,000
-0.7%
249,124
-0.2%
0.84%
+14.3%
Q3 2018$21,517,000
+13.1%
249,738
-0.9%
0.74%
+4.7%
Q2 2018$19,032,000
-5.4%
251,951
+1.2%
0.71%
-6.4%
Q1 2018$20,121,000
-5.5%
248,867
-1.8%
0.75%
-0.8%
Q4 2017$21,283,000
-2.0%
253,488
+0.2%
0.76%
-5.7%
Q3 2017$21,728,000
+0.6%
253,090
-2.2%
0.81%
-1.8%
Q2 2017$21,599,000
+10.9%
258,768
-1.3%
0.82%
+7.6%
Q1 2017$19,478,000
-5.7%
262,253
-7.5%
0.76%
-9.6%
Q4 2016$20,657,000
-9.3%
283,596
-1.7%
0.84%
-10.7%
Q3 2016$22,774,000
-5.8%
288,427
-1.6%
0.94%
-6.6%
Q2 2016$24,174,000
+15.4%
292,978
+1.3%
1.01%
+13.5%
Q1 2016$20,953,000
-15.3%
289,244
+0.7%
0.89%
-16.8%
Q4 2015$24,724,000
-4.5%
287,350
+2.0%
1.07%
-9.0%
Q3 2015$25,899,000
-7.5%
281,753
-1.1%
1.18%
-0.3%
Q2 2015$28,007,000
+1.3%
284,801
+1.6%
1.18%
-0.7%
Q1 2015$27,646,000
+6.0%
280,359
-0.4%
1.19%
+6.2%
Q4 2014$26,092,000
-2.2%
281,584
-0.6%
1.12%
-4.9%
Q3 2014$26,678,000
+4.3%
283,415
+0.3%
1.18%
+4.3%
Q2 2014$25,569,000
+9.2%
282,439
+0.3%
1.13%
+3.5%
Q1 2014$23,420,000
+4.3%
281,558
+0.8%
1.09%
+3.7%
Q4 2013$22,453,000
+6.9%
279,331
+2.0%
1.05%
-2.8%
Q3 2013$21,011,000
+10.2%
273,908
+1.6%
1.08%
+4.7%
Q2 2013$19,066,000269,6361.03%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders